OncoCyte Corporation Made Headway
Thu, Mar 16, 2023 at 07:11 PM
OncoCyte Corporation (OCX:NASDAQ) rocketted at $0.3, representing a gain of 51.5%. The stock got featured on our News Catalysts scanner on Wed, Mar 15, 2023 at 04:40 PM in the 'EARNINGS' category. From Thu, Mar 02, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
About OncoCyte Corporation (OCX:NASDAQ)
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Top 10 Gainers:
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 97.59%
- OncoCyte Corporation (OCX:NASDAQ), 51.5%
- Baudax Bio, Inc. (BXRX:NASDAQ), 44.36%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 43.2%
- PureCycle Technologies Inc. (PCT:NASDAQ), 39.41%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 39.11%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 34.04%
- Peak Bio Inc Com (PKBO:NASDAQ), 31.56%
- Genelux Corporation (GNLX:NASDAQ), 27.78%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSE), 25.81%